Two Sigma Securities’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $394K | Buy |
4,480
+1,282
| +40% | +$113K | 0.05% | 536 |
|
|
2025
Q1 | $291K | Buy |
+3,198
| New | +$291K | 0.04% | 600 |
|
|
2023
Q2 | – | Sell |
-3,771
| Closed | -$293K | – | 1754 |
|
|
2023
Q1 | $293K | Buy |
+3,771
| New | +$293K | 0.01% | 616 |
|
|
2022
Q4 | – | Sell |
-4,319
| Closed | -$290K | – | 1856 |
|
|
2022
Q3 | $290K | Buy |
+4,319
| New | +$290K | 0.01% | 621 |
|
|
2021
Q2 | – | Sell |
-3,178
| Closed | -$219K | – | 975 |
|
|
2021
Q1 | $219K | Buy |
+3,178
| New | +$219K | 0.01% | 393 |
|
|
2018
Q3 | – | Sell |
-4,483
| Closed | -$264K | – | 1517 |
|
|
2018
Q2 | $264K | Buy |
+4,483
| New | +$264K | ﹤0.01% | 660 |
|
|
2018
Q1 | – | Sell |
-6,294
| Closed | -$374K | – | 1496 |
|
|
2017
Q4 | $374K | Buy |
+6,294
| New | +$374K | 0.01% | 329 |
|
|
2017
Q1 | – | Sell |
-4,273
| Closed | -$224K | – | 1070 |
|
|
2016
Q4 | $224K | Buy |
4,273
+303
| +8% | +$15.9K | 0.07% | 379 |
|
|
2016
Q3 | $228K | Buy |
+3,970
| New | +$228K | 0.08% | 391 |
|